SAFLUTAN gtt opht 30 monodos 0.3 ml

7680605480013 CH-60548 S01EE05 11.09.0.
SAFLUTAN gtt opht 30 monodos 0.3 ml
SAFLUTAN gtt opht 30 monodos 0.3 ml
1 / 2
google

Details

Product number
6054801
CPT
-
Packaging group
30
Unit
Einzeldose(n)
Composition
tafluprostum 15 µg, glycerolum, natrii dihydrogenophosphas dihydricus corresp. phosphas 1.2 mg, dinatrii edetas, polysorbatum 80, acidum hydrochloridum aut natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml.

Articles (1)

Saflutan, unidose de collyre
Augentropfen
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
08/07/2021
Patient information leaflet
Français
08/07/2021
Patient information leaflet
Italien
08/07/2021
Professional SmPC
Allemand
08/07/2021
Professional SmPC
Français
08/07/2021
Professional SmPC
Italien
08/07/2021

Detailed composition

Substance Quantity Type Category
(N/A)
15.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.2 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 37.65
Specialties list
Yes
Generic
No
SL addition date: 01/06/2010

Authorization holder

Santen SA

1202 Genève

Authorization information

Swissmedic authorization number
60548
Drug name
Saflutan, unidose de collyre
Galenic form
AUGT
ATC Code
S01EE05
Authorization status
Z
Dispensation category
B
First authorization
27/01/2010
Authorization expiration date
31/12/9999
IT number
11.09.0.
Domain
Human medicine
Field of application
Glaukom

Packaging details

Description (FR)
SAFLUTAN gtt opht 30 monodos 0.3 ml
Description (DE)
SAFLUTAN Gtt Opht 30 Monodos 0.3 ml
Market launch
27/01/2010
Narcotic (BTM)
No